Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at atezolizumab and chemotherapy for triple negative breast cancer

Overview

Cancer types:

Breast cancer

Status:

Closed

Phase:

Phase 3

Details

This trial is for people with triple negative breast cancer who are going to have treatment for the first time. Triple negative breast cancers are cancers whose cells don’t have receptors for:

  • the hormones oestrogen and progesterone

  • the Her 2 protein

Recruitment start: 26 October 2017

Recruitment end: 12 June 2018

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Samreen Ahmed

Supported by

Roche

Last reviewed: 6 October 2020

CRUK internal database number: 16405

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.